MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Proceeds from issuance of2031...$575,000K Proceeds from royaltyobligation-Royalty Interest...$300,000K Proceeds from stockoption exercises, net...$27,735K Proceeds from commonstock issuances under...$6,414K Transactions withnoncontrolling interests$2,150K Net cash provided byfinancing activities$359,293K Canceled cashflow$552,006K Net increase(decrease) in cash, cash...-$111,104K Canceled cashflow$359,293K Stock-based compensation$133,024K Noncash interestexpense on deferred...$125,138K Other liabilities$77,810K Net loss from equitymethod investments-$72,608K Accounts payable$26,609K Accrued compensationand benefits$23,022K Loss onextinguishments of debt-$21,155K Accrued research anddevelopment liabilities$7,163K Amortization of debt discountand issuance costs$5,967K Depreciation andamortization$5,434K Noncash lease expense$4,902K Other assets-$1,113K Maturities of marketablesecurities$11,000K Proceeds from specialcash dividends...$2,302K Repayment of term loans$459,000K Repurchase of common stock$48,276K Repayments of deferredroyalty obligations$15,460K Repurchase of rsu shares tosatisfy tax withholding$14,226K Issuance costs anddiscounts associated with...$12,034K Issuance costs anddiscounts associated with...$3,010K Net cash used inoperating activities-$445,910K Canceled cashflow$503,945K Net cash provided by(used in) investing...-$24,487K Canceled cashflow$13,302K Net loss-$732,938K Accounts receivable, net$134,722K Inventories$25,307K Change in fair value ofthe embedded...$19,652K Deferred revenue-$11,428K Noncash income fromequity method...$8,833K Prepaid expenses andother current assets$8,777K Operating leaseliabilities-$6,547K Other noncashadjustments, net$1,651K Purchases of marketablesecurities$28,197K Payment for intangibleassets$8,495K Purchases of property andequipment$1,097K
Cash Flow
source: myfinsight.com

BridgeBio Pharma, Inc. (BBIO)

BridgeBio Pharma, Inc. (BBIO)